Incentives for Officers and Employees Through Stock Options
First written in FY2017. 12 of 17 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-09-30.
- FY2026-H1AdvancedAnnual report
「Company employees: 118 / Number of stock acquisition rights*1: 20,480 / Class, description and number of shares underlying the stock acquisition rights*1: 2,048,000 common shares (100 common shares per stock acquisition right) / Company directors, excluding outside directors: 4 / Company executive officers, excluding those who also serve as directors: 11 / Number of stock acquisition rights*1: 7,610 / Class, description and number of shares underlying the stock acquisition rights*1: 761,000 common shares (100 common shares per stock acquisition right)」
The Company issued 2,048,000 shares of 2025 stock options to 118 employees and 761,000 shares to 4 internal directors and 11 executive officers. The exercise period is from 2 September 2027 to 31 August 2032. - FY2025RaisedAnnual report
「The Company plans to propose the issuance of stock acquisition rights as an agenda item for resolution at the annual general meeting of shareholders scheduled for 27 June 2025. The number of stock acquisition rights will be capped at 27,000, and the number of common shares will be capped at 2,700,000.」
The Company plans to expand the issuance cap for employee stock options from the previous limit of 2,100,000 shares to 2,700,000 shares. - FY2024AdvancedAnnual report
「The decrease of 24,872,290 in treasury common shares comprised a decrease of 22,431,200 shares due to cancellation, 2,441,000 shares due to the exercise of stock options, and 90 shares due to requests for the sale of odd-lot shares.」
Existing stock options covering 2,441,000 shares were exercised during the fiscal year. In addition, a proposal has been submitted to the annual general meeting of shareholders for a new issuance framework for employees, capped at 21,000 stock acquisition rights and 2,100,000 shares. - FY2024-Q3AdvancedAnnual report
「Company employees: 116 Number of stock acquisition rights*1 14,725 Class, description and number of shares underlying the stock acquisition rights*1 1,472,500 common shares (100 common shares per stock acquisition right) Exercise period for the stock acquisition rights*1 1 December 2025 to 29 November 2030」
As of 30 November 2023, stock acquisition rights for 1,472,500 shares were issued to 116 employees. In addition, stock acquisition rights for 468,500 shares were issued to 4 directors and 12 executive officers. - FY2023AdvancedAnnual report
「Eligible recipients and number: 108 Company employees / Number of stock acquisition rights: 2,526 / Class, description and number of shares underlying the stock acquisition rights: 252,600 common shares」
The grant details for employee stock options approved in June 2022 were disclosed. In addition, 2023 stock options have been issued to 5 directors and 11 executive officers. - FY2022RestatedAnnual report
「Under the 2021 stock option plan, 334,500 common shares were granted to 6 of the Company's directors, excluding outside directors, 10 of the Company's executive officers, excluding those who also serve as directors, and 107 employees. The exercise period is from 2 September 2023 to 31 August 2028.」
The full-year program disclosure confirms the eligible recipients, the grant of 334,500 shares and the exercise period for the 2021 stock options implemented in the previous fiscal year. - FY2022-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. / Company employees: 107 people / Common shares: 229,000 shares (100 common shares per stock acquisition right) / Company directors, excluding outside directors: 6 people / Company executive officers, excluding those concurrently serving as directors: 10 people / Common shares: 105,500 shares (100 common shares per stock acquisition right) / Exercise period for the stock acquisition rights: 2 September 2023 to 31 August 2028」
The disclosure states that, in the issuance dated 1 September 2021, stock acquisition rights were actually issued covering 229,000 shares for 107 employees and 105,500 shares for 6 internal directors and 10 executive officers. - FY2021AdvancedAnnual report
「The reduction of 481,351 treasury common shares comprised a reduction of 481,300 shares due to the exercise of stock options and a reduction of 51 shares due to requests for the sale of less-than-one-unit shares.」
The disclosure states that 481,300 shares under stock options granted in prior fiscal years were exercised during the current fiscal year. - FY2021-Q2AdvancedAnnual report
「Company employees: 105 people (including 5 directors also serving as employees) / Common shares: 232,000 shares (100 common shares per stock acquisition right) / Company directors, excluding outside directors: 16 people / Common shares: 107,000 shares (100 common shares per stock acquisition right)」
The disclosure states that, in the issuance dated 2 September 2020, stock acquisition rights were actually issued covering 232,000 shares for 105 employees and 107,000 shares for 16 directors excluding outside directors. - FY2020-Q2AdvancedAnnual report
「Company employees: 100 people (including 5 directors also serving as employees) / Common shares: 344,000 shares (100 common shares per stock acquisition right) / Company directors, excluding outside directors: 17 people / Common shares: 200,000 shares (100 common shares per stock acquisition right)」
The disclosure states that, for the 2019 stock acquisition rights, rights were actually issued covering 344,000 shares for 100 employees and 200,000 shares for 17 directors excluding outside directors. The exercise period for both runs from 1 October 2020 through 31 March 2024. - FY2019RaisedAnnual report
「Company employees / Up to 4,600 stock acquisition rights / Up to 460,000 common shares / From the day following the corresponding date one year after the allotment date through 31 March 2024」
The new issuance limit for employee stock acquisition rights was increased from the previously disclosed ceiling of 450,000 shares to 460,000 shares, and the exercise deadline was extended through 31 March 2024. - FY2019-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. / Company employees: 94 people (including 5 directors also serving as employees) / Common shares: 322,000 shares (100 common shares per stock acquisition right) / Company directors, excluding outside directors: 18 people / Common shares: 175,000 shares (100 common shares per stock acquisition right)」
The disclosure states that, in the issuance dated 5 September 2018, stock acquisition rights were actually issued covering 322,000 shares for 94 employees and 175,000 shares for 18 internal directors. - FY2018RaisedAnnual report
「Up to 4,500 stock acquisition rights / Up to 450,000 common shares (100 common shares per stock acquisition right) / From the day following the corresponding date one year after the allotment date through 31 March 2023」
In addition to the 235,000 shares under the existing 2017 stock option program, the company established a new issuance limit of up to 450,000 shares for employees, with an exercise period through 31 March 2023. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. / Number of stock acquisition rights (units) 1,005 / Number of underlying shares (shares) 100,500 / Exercise period: 22 September 2018 to 31 March 2022 / Number of stock acquisition rights (units) 1,345 / Number of underlying shares (shares) 134,500 / Exercise period: 22 September 2018 to 31 March 2022」
For stock acquisition rights granted to employees and others, the disclosure describes the issuance of a total of 2,350 units covering 235,000 underlying shares and their exercise period, showing that the program had progressed from setting an issuance limit to actual issuance. - FY2017First statedAnnual report
「At the ordinary general meeting of shareholders held on 29 June 2017, the Company resolved to issue stock acquisition rights to its employees, covering up to 450,000 underlying shares. The exercise period runs from the day following the corresponding date one year after the allotment date through 31 March 2022.」
For employees, the company established an issuance limit of stock acquisition rights covering up to 450,000 shares and an exercise period through 31 March 2022.